FDA Clearance Tracker · P110033-S090
Juvederm Voluma XC
Last checked: Nov 20, 2026Latest source record: Jan 17, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Jan 17, 2025
Approved
Time to decision
86 days
Received Oct 23, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
Device type
- Device type
- Implant, dermal, for aesthetic use (LMH)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for removing the lower limit of the free HA specification for the manufacture of Juvederm Voluma XC.
Source documents
Other decisions for Allergan
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- SKINVIVE by JUVEDERM®PMA supplement
P110033-S099 · Decided Jun 11, 2026 · 394 days after receipt · Panel Track
Device type: Implant, dermal, for aesthetic use (LMH) · General & Plastic Surgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.